stars 1 stars 2 stars 3

Rahko was acquired by Odyssey Therapeutics in 2021. Odyssey Therapeutics is a biotech company pioneering next gen immunomodulators and oncology medicine. Read more: https://odysseytx.com/news/

Website http://www.rahko.ai
Employees 8 (0 on RocketReach)
Technologies
Industry Software Development, Computer, Consumer Electronics, Hardware, Machine Learning, Artificial Intelligence, Data and Analytics, Software
Keywords Immunotherapy, Cell Therapy, Oncology, Immunomodulators, Oncology Drugs, Biotechnology, Drug Development, Pharmaceutical, Biopharma, Therapeutics, Medicine, Cancer Treatment, Next Generation Therapeutics, Precision Medicine, Clinical Trials, Drug Discovery, Biotech Acquisitions, Healthcare, Life Sciences, Research And Development

Rahko Questions

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users